News: Lynparza may be able to treat more breast cancers

moderators

Lynparza is a PARP inhibitor used to treat breast cancer in people with an inherited BRCA mutation. A small study found that Lynparza could also treat metastatic breast cancer in people with an inherited PALB2 mutation or who have breast cancer that has developed a BRCA mutation over time. This means that many more people might be able to receive Lynparza.